US Bancorp
CLBT icon

US Bancorp’s Cellebrite CLBT Stock Holding History

US Bancorp’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Sell
10,816
-1,034
-9% -$13.7K ﹤0.01% 2217
2026
Q1 		$163K Buy
11,850
+11,684
+7,039% +$176K ﹤0.01% 2117
2025
Q4 		$2.99K Sell
166
-886
-84% -$15.9K ﹤0.01% 3673
2025
Q3 		$19.5K Sell
1,052
-14,540
-93% -$228K ﹤0.01% 3083
2025
Q2 		$249K Sell
15,592
-255
-2% -$4.55K ﹤0.01% 1903
2025
Q1 		$308K Buy
+15,847
New +$334K ﹤0.01% 1766

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

US Bancorp's CLBT Position: Q2 2026 in Review

US Bancorp reduced its Cellebrite (CLBT) stake by 8.7% in Q2 2026, selling an estimated $13.7K and leaving 10,816 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #2217.

US Bancorp first reported a position in CLBT in Q1 2025 and has held it in 6 quarters since. The position peaked at $308K in Q1 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • US Bancorp held 10,816 shares of Cellebrite worth $158K as of Q2 2026.
  • US Bancorp sold 1,034 Cellebrite shares in Q2 2026, an estimated $13.7K.
  • Cellebrite made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2217 holding.
  • US Bancorp first reported a position in Cellebrite in Q1 2025 and has held it in 6 quarters since.
  • US Bancorp's Cellebrite position peaked at $308K in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.